Hematology NewsWhen CPI fails, HL patients should get timely allo-HCTApril 15, 2022Hodgkin LymphomaTransplantCLL
Hematology NewsSurvivor’s story foreshadows one of oncology’s greatest successesApril 14, 2022Hodgkin LymphomaTransplantCLL
Hematology NewsA little-known offshoot of hem/onc opens pathway for professional developmentMarch 31, 2022Mixed TopicsBusiness of MedicineCLL
Hematology NewsEating olive oil may slow CLL disease progressionMarch 22, 2022CLLLeukemia, Myelodysplasia, Transplantation
Hematology NewsRepurposed drug could revolutionize stem cell transplantationMarch 18, 2022TransplantB Cell LymphomaHodgkin LymphomaMultiple MyelomaPediatricsDLBCLCLL
Hematology NewsHodgkin-directed therapy may benefit patients with rare CLL subtypeMarch 10, 2022CLLHodgkin Lymphoma
Hematology TimesGlobal data suggest rising CLL incidence since 1990February 25, 2022Leukemia, Myelodysplasia, TransplantationCLL
Hematology TimesResearchers tout new CLL prognostic toolFebruary 23, 2022Lymphoma & Plasma Cell DisordersCLL
Oncology PracticeWomen at higher risk of serious adverse events from cancer therapyFebruary 17, 2022Patient & Survivor CareGastrointestinal CancerLung CancerLeukemia, Myelodysplasia, TransplantationImmunotherapyCLL
Hematology NewsFDA investigates possible increased risk of death with lymphoma drugFebruary 4, 2022CLLIndolent Lymphoma
Hematology NewsCLL patients ‘cured’: 10 years post infusion, CAR T cells persistFebruary 3, 2022CLLALLCellular Therapy
